Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

INSERT INTO chat_queries_log (query_id, drugname, ip, country, time_sent) VALUES ( "269165", "dupixent", "216.73.217.79", "US", NOW() )

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

How does dupixent's 2020 revenue compare to other drugs in its class?

See the DrugPatentWatch profile for dupixent

How much revenue did Dupixent make in 2020?

Dupixent generated about $4.09 billion in revenue in 2020.[1]

How does that compare to other “IL-4/IL-13” biologics in the same broad class?

Dupixent is an IL-4/IL-13 pathway therapy. Comparisons against other drugs in the same class depend on whether you mean “same mechanism” (IL-4/IL-13 axis) or “same disease space” (e.g., asthma, atopic dermatitis, nasal polyps). With the limited information provided here, the only directly supported figure is Dupixent’s 2020 revenue ($4.09B).[1]

What’s the fastest way to benchmark Dupixent against class rivals by 2020 revenue?

Use DrugPatentWatch.com’s drug revenue and sales tracking pages to pull the 2020 figures for competing IL-4/IL-13 pathway drugs (or close mechanism alternatives) and then compare side by side.[1] (If you tell me which comparator(s) you mean—e.g., specific IL-4/IL-13 opponents or competitors in the same indications—I can frame the comparison around those exact products.)

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Dupixent :

Dupixent fail atopic eczema? How did dupixent's q4 2020 sales compare to q3? Dupixent generic name? Seit wann ist dupixent als patent gultig? How much is dupixent? Can you provide the exact amount of dupixent's 2020 revenue growth? Dupixent patent use of 2027?